Mapping Cell Surface Proteosome to Discover Proximity Drugs

InduPro specializes in proximity-based therapeutics, focusing on the spatial relationships of proteins on cell surfaces to unlock new treatment possibilities for various diseases. Their proprietary ProXiMATE™ engine provides insights into proximity biology, enabling the development of a differentiated pipeline of therapies, particularly in oncology and immunology. The company employs a unique approach that involves mapping the cell surface proteome and utilizing advanced technologies to identify and manipulate protein interactions, which can lead to innovative drug therapies that address unmet medical needs.

Central to InduPro's strategy is their MInt platform, which leverages artificial intelligence and machine learning to analyze protein microenvironments and define the architecture of the cell surface proteome. This allows for the identification of novel therapeutic targets and co-target pairs, facilitating selective tumor targeting and immunological synapse modulation. By focusing on tumor-associated proximity antigens (TAPAs), InduPro aims to enhance the specificity of their therapies, overcoming challenges associated with traditional targeting methods. Their dual approach of inherent and induced proximity not only fosters the discovery of new protein interactions but also creates new therapeutic paradigms, ultimately leading to more effective and safer medicines for patients.

United States

InduPro is a biotechnology company that brings proteins on the cell surface closer together, manipulating their interactions and opening new possibilities for treating various conditions.

InduPro

Company Details